AlgiPharma AS: Clinical Trials

2 trials sponsored by AlgiPharma AS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow AlgiPharma AS: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis
OligoG CF-5/20, Saline - Cystic Fibrosis
Phase 1 / Phase 2CompletedAlgiPharma AS262011-05-012015-01-14
Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis
OligoG CF-5/20 - Cystic Fibrosis
Phase 1CompletedAlgiPharma AS262009-09-012016-03-23

Conditions studied

Cystic Fibrosis (2)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Lung Diseases (1)  ·  Pancreatic Diseases (1)  ·  Respiratory Tract Diseases (1)

Interventions

oligoG CF-5-20 (2)  ·  Sodium Chloride (1)

Countries

United Kingdom (2)  ·  Ireland (1)

Top investigators

Martin Walshaw, MD (1)  ·  Salvatore Febbraro (1)